North America Insulin Pens Market to 2027 - Regional Analysis and Forecasts By Product Type (Disposable and Reusable); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography
- THE3243827
- 114 Pages
- July 2019
- Medical Devices
The growth of the insulin pen market is primarily attributed to the growing geriatric population and rising incidence of diabetes. However, availability of alternatives for drug delivery and limitations associated with insulin pens are likely to pose a negative impact on the market growth. On the other hand, development of cost efficient pen needles is likely to have a positive impact on the growth of the North America insulin pen market in the coming years.
Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipid us and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. Diabetes type 2 is the most common form, according to International Diabetes Federation (IDF), approximately 425 million people were living with diabetes in 2017and it is expected to reach 629 million by 2045 across the globe. In 2015, around 9.4% of the population of the U.S. had diabetes, including 30.2 million adults aged 18 years and over. Additionally, according to Centers for Disease Control and Prevention's report that 4% of people aged 18 to 44 years are living with diabetes, 17 percent of those aged 45 to 64 years, and 25.2 percent of those aged over 65 years are living with diabetes. The following table represents number of patients suffering with diabetes across various North American countries worldwide.
In 2018, the disposable segment held a largest market share of 62.5% of the insulin pen market, by product. The disposable is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and presence of the several market players that offers technically advanced products. The disposable segment is also anticipated to witness the fastest growth rate of 8.9% during the forecast period, 2019 to 2027.
Retail pharmacies segment a largest market share of 39.8% of the insulin pen market, by distribution channel in 2018. This segment is also expected to dominate the market in 2027 owing Chemists and retail pharmacies are considered to be the most preferred channel for patients using diabetes insulin pens. Retail pharmacies are among the most go-to places opted by the patients resulting in the high share and growth of the segment in the insulin pens market over the coming years. E-Commerce segment is also expected to grow at the fastest growth rate of 9.1% during the forecast period, 2019 to 2027.
Some of the major primary and secondary sources for insulin pen included in the report are, Owen Mumford, LTD., Novo Nordisk a/s, Companion Medical , Berlin-Chemie AG, Pendiq GmbH, Emperra GmbH E-Health Technologies, Eli lilly and company, Ypsomed Ag, SANOFI, Biocon, and others.
Part 1.Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
Part 2.North America Diabetes Care Devices Market – Key Takeaways
Part 3.North America Diabetes Care Devices Market – Market Landscape
3.1 overview
3.2 market segmentation
3.2.1 North America Diabetes Care Devices Market – By Product
3.2.2 North America Diabetes Care Devices Market – By End USer
3.2.3 North America Diabetes Care Devices Market – By Country
3.3 PEST Analysis
Part 4.North America Diabetes Care Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Geriatric Population
4.1.2 Rapid Technological Advancements in Diabetes Care Devices
4.2 Key Market Restraints
4.2.1 High Cost of Diabetes Care Devices
4.2.2 Risks Associated with the Insulin Delivery Devices
4.3 Key Market Opportunities
4.3.1 Development of Cost Efficient Pen Needles
4.4 future Trends
4.4.1 Growing Product Innovations
4.5 Impact analysis
Part 5.Diabetes Care Devices Market – North America Analysis
5.1 North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Medtronic
5.3.2 F. Hoffmann-La Roche Ltd.
Part 6.North America Diabetes Care Devices Market Analysis – By Product
6.1 overview
6.2 North America diabetes care devices Market BY Product, 2018 & 2027 (%)
6.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.4 Glucose Monitoring Devices Market
6.4.1 Overview
6.4.2 North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Glucometers Market
6.4.3.1 Overview
6.4.3.2 North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Lancets Market
6.4.4.1 Overview
6.4.4.2 North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Testing Strips Market
6.4.5.1 Overview
6.4.5.2 North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)
6.4.6 Other Glucose Monitoring Devices Market
6.4.6.1 Overview
6.4.6.2 North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Insulin Delivery Devices Market
6.5.1 Overview
6.5.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Insulin Pens Market
6.5.3.1 Overview
6.5.3.2 North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Insulin Syringes Market
6.5.4.1 Overview
6.5.4.2 North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Insulin Pumps Market
6.5.5.1 Overview
6.5.5.2 North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Other Insulin Delivery Devices Market
6.5.6.1 Overview
6.5.6.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
Part 7.North America Diabetes Care Devices Market Analysis – By End USer
7.1 Overview
7.2 NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)
7.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
7.4 Homecare MArket
7.4.1 Overview
7.4.2 North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 hospitals & Clinics Market
7.5.1 Overview
7.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Part 8.North America Diabetes Care Devices Market Revenue And Forecasts To 2027
8.1 Overview
8.2 North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.5 North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)
8.6 US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.6.1 US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.2.1 US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.2 US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.3 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.7 Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.1 Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.2.1 Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2 Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.3 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.8 Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.1 Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.2.1 Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2 Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.3 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
Part 9.Diabetes Care Devices Market – Industry Landscape
9.1 Overview
9.2 Comparative Company Analysis
9.3 Growth Strategies done by the companies in the Market, (%)
9.4 Organic Developments
9.4.1 Overview
9.5 Inorganic developments
9.5.1 Overview
Part 10.Diabetes Care Devices Market–Key Company Profiles
10.1 BD
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 novo nordisk a/s
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 B. Braun Melsungen AG
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Medtronic
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Tandem Diabetes Care, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Insulet Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Eli lilly and company
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dexcom, Inc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Terumo Corporation
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product portfolio
10.9.5 SWOT ANALYSIS
10.9.6 KEY DEVELOPMENTS
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
Part 11.Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
Table 1. Total Number Of Persons Of aged 60 Years Or Above By Region, 2017 & 2050
Table 2. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 3. North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 4. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 5. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 6. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 7. North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 8. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 9. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 10. US Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 11. US Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 12. US Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 13. US Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 14. Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 15. Canada Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 16. Canada Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 17. Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 18. Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 19. Mexico Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 20. Mexico Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 21. Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 22. Organic Developments Done By Companies
Table 23. Inorganic Developments Done By Companies
Table 24. Glossary Of Terms, Diabetes Care Devices Market
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
